SNX30 inhibits lung adenocarcinoma cell proliferation and induces cell ferroptosis through regulating SETDB1

Abstract Background Lung adenocarcinoma is the most common form of lung cancer and one of the most life-threatening malignant tumors. Ferroptosis is an iron-dependent regulatory cell death pathway that is crucial for tumor growth. SNX30 is a key regulatory factor in cardiac development; however, its...

Full description

Saved in:
Bibliographic Details
Main Authors: Xinjie Fan, Qichu Zhu, Chengzhuo Du, Jinlai Chen, Yingming Su
Format: Article
Language:English
Published: BMC 2025-01-01
Series:Journal of Cardiothoracic Surgery
Subjects:
Online Access:https://doi.org/10.1186/s13019-024-03298-2
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841544290516336640
author Xinjie Fan
Qichu Zhu
Chengzhuo Du
Jinlai Chen
Yingming Su
author_facet Xinjie Fan
Qichu Zhu
Chengzhuo Du
Jinlai Chen
Yingming Su
author_sort Xinjie Fan
collection DOAJ
description Abstract Background Lung adenocarcinoma is the most common form of lung cancer and one of the most life-threatening malignant tumors. Ferroptosis is an iron-dependent regulatory cell death pathway that is crucial for tumor growth. SNX30 is a key regulatory factor in cardiac development; however, its regulatory mechanism and role in inducing ferroptosis in lung adenocarcinoma remain unclear. Objective This study aimed to elucidate the functions and specific mechanisms of action of SNX30 in lung adenocarcinomas. Methods SNX30 levels in lung adenocarcinoma cell lines (A549 and HCC827) were determined using reverse transcription quantitative real-time PCR (RT-qPCR) or western blotting. Cell proliferation and apoptosis were assessed by CCK8 and flow cytometry, respectively. The intracellular levels of total iron and Fe2+ were detected using Iron Assay Kits. Reactive oxygen species (ROS) levels were evaluated using a DCFH-DA probe and flow cytometry. Cysteine (Cys), glutathione (GSH), and glutathione peroxidase 4 (GPX4) levels were measured using detection assay kits. Other related markers, including Ptgs2, Chac1, SETDB1 cleaved-Caspase3, and Caspase3 were analyzed by RT-qPCR or western blotting. Results SNX30 is downregulated in lung adenocarcinoma cell lines. SNX30-plasmid depressed lung adenocarcinoma cell proliferation, accelerated apoptosis, enhanced cleaved-Caspase3 expression and cleaved-Caspase3/Caspase3 ratio. Ferrostatin-1 significantly reversed the effects of the SNX30-plasmid on cell ferroptosis in lung adenocarcinoma, as confirmed by the reduced ROS levels, inhibited intracellular total iron and Fe2+ levels, decreased Ptgs2 and Chac1 expression, and increased Cys, GSH, and GPX4 release. We observed that the level of SETDB1 was lower in the SNX30-plasmid group than in the control-plasmid group, whereas the opposite results in ferrostatin-1 treated cells. SNX30 negatively regulates SETDB1 expression in lung adenocarcinoma cells. The upregulation of SETDB1 reversed the effects of the SNX30-plasmid on ferroptosis in lung adenocarcinoma cells. Conclusion SNX30 inhibits lung adenocarcinoma cell proliferation and induces ferroptosis by regulating SETDB1 expression.
format Article
id doaj-art-79a4bd39117b456197d1274fae82e4fd
institution Kabale University
issn 1749-8090
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series Journal of Cardiothoracic Surgery
spelling doaj-art-79a4bd39117b456197d1274fae82e4fd2025-01-12T12:38:55ZengBMCJournal of Cardiothoracic Surgery1749-80902025-01-0120111010.1186/s13019-024-03298-2SNX30 inhibits lung adenocarcinoma cell proliferation and induces cell ferroptosis through regulating SETDB1Xinjie Fan0Qichu Zhu1Chengzhuo Du2Jinlai Chen3Yingming Su4Department of Respiratory and Critical Care Medicine, Datian County General HospitalDepartment of Respiratory and Critical Care Medicine, Datian County General HospitalDepartment of Respiratory and Critical Care Medicine, Datian County General HospitalDepartment of Respiratory and Critical Care Medicine, Datian County General HospitalDepartment of Respiratory and Critical Care Medicine, Datian County General HospitalAbstract Background Lung adenocarcinoma is the most common form of lung cancer and one of the most life-threatening malignant tumors. Ferroptosis is an iron-dependent regulatory cell death pathway that is crucial for tumor growth. SNX30 is a key regulatory factor in cardiac development; however, its regulatory mechanism and role in inducing ferroptosis in lung adenocarcinoma remain unclear. Objective This study aimed to elucidate the functions and specific mechanisms of action of SNX30 in lung adenocarcinomas. Methods SNX30 levels in lung adenocarcinoma cell lines (A549 and HCC827) were determined using reverse transcription quantitative real-time PCR (RT-qPCR) or western blotting. Cell proliferation and apoptosis were assessed by CCK8 and flow cytometry, respectively. The intracellular levels of total iron and Fe2+ were detected using Iron Assay Kits. Reactive oxygen species (ROS) levels were evaluated using a DCFH-DA probe and flow cytometry. Cysteine (Cys), glutathione (GSH), and glutathione peroxidase 4 (GPX4) levels were measured using detection assay kits. Other related markers, including Ptgs2, Chac1, SETDB1 cleaved-Caspase3, and Caspase3 were analyzed by RT-qPCR or western blotting. Results SNX30 is downregulated in lung adenocarcinoma cell lines. SNX30-plasmid depressed lung adenocarcinoma cell proliferation, accelerated apoptosis, enhanced cleaved-Caspase3 expression and cleaved-Caspase3/Caspase3 ratio. Ferrostatin-1 significantly reversed the effects of the SNX30-plasmid on cell ferroptosis in lung adenocarcinoma, as confirmed by the reduced ROS levels, inhibited intracellular total iron and Fe2+ levels, decreased Ptgs2 and Chac1 expression, and increased Cys, GSH, and GPX4 release. We observed that the level of SETDB1 was lower in the SNX30-plasmid group than in the control-plasmid group, whereas the opposite results in ferrostatin-1 treated cells. SNX30 negatively regulates SETDB1 expression in lung adenocarcinoma cells. The upregulation of SETDB1 reversed the effects of the SNX30-plasmid on ferroptosis in lung adenocarcinoma cells. Conclusion SNX30 inhibits lung adenocarcinoma cell proliferation and induces ferroptosis by regulating SETDB1 expression.https://doi.org/10.1186/s13019-024-03298-2SNX30Lung adenocarcinomaFerroptosisSETDB1
spellingShingle Xinjie Fan
Qichu Zhu
Chengzhuo Du
Jinlai Chen
Yingming Su
SNX30 inhibits lung adenocarcinoma cell proliferation and induces cell ferroptosis through regulating SETDB1
Journal of Cardiothoracic Surgery
SNX30
Lung adenocarcinoma
Ferroptosis
SETDB1
title SNX30 inhibits lung adenocarcinoma cell proliferation and induces cell ferroptosis through regulating SETDB1
title_full SNX30 inhibits lung adenocarcinoma cell proliferation and induces cell ferroptosis through regulating SETDB1
title_fullStr SNX30 inhibits lung adenocarcinoma cell proliferation and induces cell ferroptosis through regulating SETDB1
title_full_unstemmed SNX30 inhibits lung adenocarcinoma cell proliferation and induces cell ferroptosis through regulating SETDB1
title_short SNX30 inhibits lung adenocarcinoma cell proliferation and induces cell ferroptosis through regulating SETDB1
title_sort snx30 inhibits lung adenocarcinoma cell proliferation and induces cell ferroptosis through regulating setdb1
topic SNX30
Lung adenocarcinoma
Ferroptosis
SETDB1
url https://doi.org/10.1186/s13019-024-03298-2
work_keys_str_mv AT xinjiefan snx30inhibitslungadenocarcinomacellproliferationandinducescellferroptosisthroughregulatingsetdb1
AT qichuzhu snx30inhibitslungadenocarcinomacellproliferationandinducescellferroptosisthroughregulatingsetdb1
AT chengzhuodu snx30inhibitslungadenocarcinomacellproliferationandinducescellferroptosisthroughregulatingsetdb1
AT jinlaichen snx30inhibitslungadenocarcinomacellproliferationandinducescellferroptosisthroughregulatingsetdb1
AT yingmingsu snx30inhibitslungadenocarcinomacellproliferationandinducescellferroptosisthroughregulatingsetdb1